250 related articles for article (PubMed ID: 21908732)
1. TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation.
Vire B; David A; Wiestner A
J Immunol; 2011 Oct; 187(8):4040-50. PubMed ID: 21908732
[TBL] [Abstract][Full Text] [Related]
2. Identification of TOSO/FAIM3 as an Fc receptor for IgM.
Shima H; Takatsu H; Fukuda S; Ohmae M; Hase K; Kubagawa H; Wang JY; Ohno H
Int Immunol; 2010 Mar; 22(3):149-56. PubMed ID: 20042454
[TBL] [Abstract][Full Text] [Related]
3. Identity of the elusive IgM Fc receptor (FcmuR) in humans.
Kubagawa H; Oka S; Kubagawa Y; Torii I; Takayama E; Kang DW; Gartland GL; Bertoli LF; Mori H; Takatsu H; Kitamura T; Ohno H; Wang JY
J Exp Med; 2009 Nov; 206(12):2779-93. PubMed ID: 19858324
[TBL] [Abstract][Full Text] [Related]
4. TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia.
Zhang YR; Yu Z; Xiong WJ; Liu XX; Liu HM; Cui R; Wang Q; Chen WM; Qiu LG; Yi SH
Chin Med J (Engl); 2020 Sep; 133(17):2090-2097. PubMed ID: 32784334
[TBL] [Abstract][Full Text] [Related]
5. Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.
Li FJ; Kubagawa Y; McCollum MK; Wilson L; Motohashi T; Bertoli LF; Barton JC; Barnes S; Davis RS; Kubagawa H
Blood; 2011 Nov; 118(18):4902-9. PubMed ID: 21908424
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia.
Vire B; Skarzynski M; Thomas JD; Nelson CG; David A; Aue G; Burke TR; Rader C; Wiestner A
Cancer Res; 2014 Dec; 74(24):7510-7520. PubMed ID: 25344228
[TBL] [Abstract][Full Text] [Related]
7. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.
Ouchida R; Mori H; Hase K; Takatsu H; Kurosaki T; Tokuhisa T; Ohno H; Wang JY
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):E2699-706. PubMed ID: 22988094
[TBL] [Abstract][Full Text] [Related]
8. Unique ligand-binding property of the human IgM Fc receptor.
Honjo K; Kubagawa Y; Kearney JF; Kubagawa H
J Immunol; 2015 Feb; 194(4):1975-82. PubMed ID: 25601920
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.
Faitschuk E; Hombach AA; Frenzel LP; Wendtner CM; Abken H
Blood; 2016 Sep; 128(13):1711-22. PubMed ID: 27535994
[TBL] [Abstract][Full Text] [Related]
10. Fcμ receptor as a Costimulatory Molecule for T Cells.
Meryk A; Pangrazzi L; Hagen M; Hatzmann F; Jenewein B; Jakic B; Hermann-Kleiter N; Baier G; Jylhävä J; Hurme M; Trieb K; Grubeck-Loebenstein B
Cell Rep; 2019 Mar; 26(10):2681-2691.e5. PubMed ID: 30840890
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for Fc receptor recognition of immunoglobulin M.
Chen Q; Menon RP; Masino L; Tolar P; Rosenthal PB
Nat Struct Mol Biol; 2023 Jul; 30(7):1033-1039. PubMed ID: 37095205
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.
Kubagawa Y; Honjo K; Kang DW; Kubagawa H
Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):393-400. PubMed ID: 25545208
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin M perception by FcμR.
Li Y; Shen H; Zhang R; Ji C; Wang Y; Su C; Xiao J
Nature; 2023 Mar; 615(7954):907-912. PubMed ID: 36949194
[TBL] [Abstract][Full Text] [Related]
14. Role of the IgM Fc Receptor in Immunity and Tolerance.
Liu J; Wang Y; Xiong E; Hong R; Lu Q; Ohno H; Wang JY
Front Immunol; 2019; 10():529. PubMed ID: 30967868
[TBL] [Abstract][Full Text] [Related]
15. The IgM receptor FcμR limits tonic BCR signaling by regulating expression of the IgM BCR.
Nguyen TT; Kläsener K; Zürn C; Castillo PA; Brust-Mascher I; Imai DM; Bevins CL; Reardon C; Reth M; Baumgarth N
Nat Immunol; 2017 Mar; 18(3):321-333. PubMed ID: 28135254
[TBL] [Abstract][Full Text] [Related]
16. FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.
Gupta S; Agrawal S; Gollapudi S; Kubagawa H
Hum Immunol; 2016 Dec; 77(12):1194-1201. PubMed ID: 27751883
[TBL] [Abstract][Full Text] [Related]
17. FcμR interacts and cooperates with the B cell receptor To promote B cell survival.
Ouchida R; Lu Q; Liu J; Li Y; Chu Y; Tsubata T; Wang JY
J Immunol; 2015 Apr; 194(7):3096-101. PubMed ID: 25732732
[TBL] [Abstract][Full Text] [Related]
18. The old but new IgM Fc receptor (FcμR).
Kubagawa H; Kubagawa Y; Jones D; Nasti TH; Walter MR; Honjo K
Curr Top Microbiol Immunol; 2014; 382():3-28. PubMed ID: 25116093
[TBL] [Abstract][Full Text] [Related]
19. The long elusive IgM Fc receptor, FcμR.
Kubagawa H; Oka S; Kubagawa Y; Torii I; Takayama E; Kang DW; Jones D; Nishida N; Miyawaki T; Bertoli LF; Sanders SK; Honjo K
J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S35-45. PubMed ID: 24793544
[TBL] [Abstract][Full Text] [Related]
20. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
